technology
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
arstechnica.com • 18 Jun 2026, 22:08
In February, a Trump official refused to review the vaccine.
Les originalartikkelen
Mere fra arstechnica.com
- As China looms, Taiwan makes more drones for defense and the US military
- NASA's $1.1 billion Gateway habitation module is unlikely to be used for something else
- Google shares updated timeline for rolling out Android developer verification
- Apple patches high-severity eavesdropping vulnerability in Beats Studio Buds
Relaterte artikler etter nøkkelord
review
- Transform Your PC into an Xbox: Step-by-Step Guide to Windows 11 Xbox Mode
- Stickies App on Mac: Why You Should Revisit This Free Built-In Note Tool
- Apple scrambles to handle component price hikes
- Why Did the U.S. Government Ban Anthropic's Most Advanced AI Model?
- Got a Google Pixel? Find these 4 Android 17 features ASAP
vaccine
- COVID vaccines still protect against heart problems, large study finds
- Bucking RFK Jr., OB-GYNs release vaccine guidance that conflicts with CDC
- The University of Cambridge says it successfully tested a vaccine with an AI-designed antigen
- Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo